Patent · US Active

Protein and autoantibody biomarkers for the diagnosis and treatment of lung cancer

US10101330B2 · kind B2 · utility

0Cited by
5References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 15, 2016
Grant dateOct 16, 2018
Priority date
Expiry dateSep 18, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/57488
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Aspects of the present disclosure include methods of producing a circulating analyte profile of a subject. The methods include contacting a blood sample from a subject with a panel of probes for specific binding to analytes, and detecting the presence or absence of binding of the analytes to probes of the panel of probes. Also provided are sensor devices including a panel of capture probes and useful, e.g., for practicing the methods of the present disclosure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.